Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coccidioides species antigens and pathogen-associated structures encompass a diverse group of molecules, including cell wall components like chitin and beta-glucans, as well as specific proteins such as Antigen 2/Proline-Rich Antigen (Ag2/PRA) and Spherule Outer Wall Glycoprotein (SOWgp) [5, 8, 18]. These structures are critical for the fungus's life cycle, facilitating the transition from environmental mycelia to pathogenic spherules within the host [18, 19]. Biologically, they serve functions ranging from maintaining cell wall integrity to mediating adhesion and evading host immune responses by masking endospores [10, 16, 23]. In the context of disease, these antigens are the primary drivers of the inflammatory response in coccidioidomycosis (Valley Fever) and are used as diagnostic markers in serological tests like complement fixation and tube precipitin assays [7, 9, 12]. Therapeutically, they are targeted by antifungal agents; for instance, Nikkomycin Z inhibits chitin synthesis, while experimental vaccines like Delta-cps1 and rCpa1 utilize these antigens to induce protective Th1 and Th17 immunity [1, 3, 11, 13]. Understanding these structures is essential for developing more effective treatments and preventative measures against this potentially life-threatening fungal infection [6, 20].
Inhibition of chitin synthase, inhibition of 1,3-beta-glucan synthase, disruption of cell membrane integrity via ergosterol binding, inhibition of ergosterol synthesis, and induction of protective cellular and humoral immunity.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coccidioides species antigens and pathogen-associated structures (Coccidioides antigens).